Biblio

60 Ergebnisse exportiert:

Filterkriterien: Autor is Jeltsch, Michael [Alle Filter deaktivieren]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Anisimov A, Alitalo A, Korpisalo P, Soronen J, Kaijalainen S, Leppänen V-M, u. a.. Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ Res [Internet]. 2009;104(11):1302 - 12. http://view.ncbi.nlm.nih.gov/pubmed/19443835

Andrey Anisimov et al., Circulation Research 2009 (8.03 MB)

Andrey Anisimov et al., Circulation Research 2009, supplement (5.9 MB)

Saaristo A, Veikkola T, Enholm B, Hytönen M, Arola J, Pajusola K, u. a.. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J [Internet]. 2002;16(9):1041 - 9. http://view.ncbi.nlm.nih.gov/pubmed/12087065

Anne Saaristo et al., FASEB Journal 2002 (966.08 KB)

B

The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. Sci Signal. 2013;6(282):ra52.

Anisimov 2013 Science Signaling (1.92 MB)

Anisimov 2013 Science Signaling Supplement (2.09 MB)

Rauniyar K, Akhondzadeh S, Gąciarz A, Künnapuu J, Jeltsch M. Bioactive VEGF-C from E. coli. Scientific Reports [Internet]. 2022;12(1). https://www.nature.com/articles/s41598-022-22960-0

Rauniyar et al. - 2022 - Bioactive VEGF-C from E. coli (4.19 MB)

C

CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation. Circulation [Internet]. 2014;129(19). http://circ.ahajournals.org/content/early/2014/02/19/CIRCULATIONAHA.113.002779.abstract

Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (6.6 MB)

Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (Suppl.) (2.38 MB)

Published version of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated... (incl. suppl.) (23.21 MB)

Saharinen P, Helotera H, Miettinen J, Norrmen C, D'Amico G, Jeltsch M, u. a.. Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev [Internet]. 2010;24(9):875 - 80. http://view.ncbi.nlm.nih.gov/pubmed/20439428

Pipsa Saharinen et al., Genes & Development 2010 (1.2 MB)

Pipsa Saharinen et al., Genes & Development 2010, supplement (9.15 MB)

Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Am J Pathol. 2012;181(5):1607-20.

D

Krebs R, Jeltsch M. Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Lymphologie in Forschung und Praxis. 2013;17(1):30-37.

Krebs R, Jeltsch M. Die lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseases of the lymphatic system. [bilingual: English, German]. Lymphologie in Forschung und Praxis [Internet]. 2013;17(2):96 - 104. http://jeltsch.org/sites/jeltsch.org/files/JeltschMichael_Lymphforsch2013_96.pdf

Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseas... (3.88 MB)

Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 2. Die Rolle von VEGF-C und VEGF-D bei ... (2.6 MB)

Tammela T, He Y, Lyytikkä J, Jeltsch M, Markkanen J, Pajusola K, u. a.. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Circ Res [Internet]. 2007;100(10):1468 - 75. http://view.ncbi.nlm.nih.gov/pubmed/17478733

Tuomas Tammela et al., Circulation Research 2007 (1.1 MB)

Jeltsch M. Drug-induced lymphangiogenesis. In 3. Schweizer Lymphsymposium [Internet]. Juzo; 2021. https://doi.org/10.5281/zenodo.6034307

Jeltsch - 2021 - Drug-induced lymphangiogenesis (1.9 MB)

E

Tvorogov D, Anisimov A, Zheng W, Leppänen V-M, Tammela T, Laurinavicius S, u. a.. Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell [Internet]. 2010;18(6):630 - 40. http://view.ncbi.nlm.nih.gov/pubmed/21130043

Denis Tvorogov et al., Cancer Cell 2010 (1.3 MB)

Denis Tvorogov et al., Cancer Cell 2010, supplement (828.69 KB)

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Scientific Reports [Internet]. 2017;7(1):4916. https://www.nature.com/articles/s41598-017-04982-1

Keskitalo S, Tammela T, Lyytikka J, Karpanen T, Jeltsch M, Markkanen J, u. a.. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ Res [Internet]. 2007;100(10):1460 - 7. http://view.ncbi.nlm.nih.gov/pubmed/17478734

Salla Keskitalo et al., Circulation Research 2007 (1.98 MB)

Rauniyar K, Bokharaie H, Jeltsch M. Expansion and collapse of VEGF diversity in major clades of the animal kingdom. Angiogenesis [Internet]. 2023;26(3):437 - 461. https://link.springer.com/10.1007/s10456-023-09874-9

Rauniyar et al. - 2023 - Expansion and collapse of VEGF diversity in major clades of the animal kingdom (3.59 MB)

F

Factors regulating the substrate specificity of cytosolic phospholipase A2-alpha in vitro. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2016;1861(11):1597.

Batchu et al. - 2016 - Factors regulating the substrate specificity of cy.pdf (986.25 KB)

From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders [Internet]. 42nd Congress of the European Society of Lymphology. Mulhouse, France; 2016. http://www.eurolymphology.org/JOURNAL/VOL28-N74-2016/#p=14

Jeltsch 2016: From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders (683.85 KB)

Functional Analysis of VEGF-B and VEGF-C [Internet]. University of Helsinki. [Helsinki]: Univeristy of Helsinki; 1997. http://urn.fi/URN:NBN:fi-fe977347

Michael Jeltsch, MSc Thesis, 1997 (3.12 MB)

Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain. Circ Res [Internet]. 2015;116(10):1660-1669. http://circres.ahajournals.org/content/116/10/1660.long

Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis. Circulation Research [Internet]. 2016;119(2):210-221. http://circres.ahajournals.org/content/early/2016/05/25/CIRCRESAHA.116.308504

Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis (3.69 MB)

Johns et al. 2016: Functional Importance of a Proteoglycan Co-Receptor in Pathologic Lymphangiogenesis: Supplemental Data (3.3 MB)

Kärpänen T, Heckman CA, Keskitalo S, Jeltsch M, Ollila H, Neufeld G, u. a.. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J [Internet]. 2006;20(9):1462 - 72. http://view.ncbi.nlm.nih.gov/pubmed/16816121

Terhi Kärpänen et al., FASEB Journal 2006 (2.51 MB)

G

Jeltsch M, Tammela T, Alitalo K, Wilting J. Genesis and pathogenesis of lymphatic vessels. Cell Tissue Res [Internet]. 2003;314(1):69 - 84. http://view.ncbi.nlm.nih.gov/pubmed/12942362

Michael Jeltsch et al., Cell and Tissue Research 2003 (562.33 KB)

The genetic causes of primary lymphedema. In Erkrankungen des Lymphgefäßsystems. 6. Aufl. Cologne: Viavital Verlag; 2015. S. 210-229.

Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB)

Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB)

H

Heterogeneity of the origin of the lymphatic system. [German]. Lymphologie in Forschung und Praxis [Internet]. 2015;19(2):84-88. http://www.dglymph.de/fileadmin/global/pdfs/LymphForsch_2-15.pdf

Mattonet & Jeltsch 2015: Heterogeneity of the origin of the lymphatic system. (3.58 MB)

Mattonet & Jeltsch 2015: Über die heterogene Herkunft des Lymphgefäßsystems. (288.77 KB)

I

Inhibiton of VEGF-C-induced VEGFR-3 activity and lymphatic endothelial cell function by the tyrosine kinase inhibitor AZD2171. In 98th Annual Meeting of the American-Association-for-Cancer-Research [Internet]. Los Angeles, CA: American Association for Cancer Research; 2007. http://dx.doi.org/10.1158/0008-5472.CAN-07-5809

Heckman et al. - 2007 - Inhibiton of VEGF-C-induced VEGFR-3 activity and l.pdf (236.37 KB)

Seiten